Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS2411 vs Omeprazole in GERD
NCT03367195Phase 3Terminated
- Sponsor
- Dexa Medica
- Start
- Aug 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Redacid in gastroesophageal reflux disease (GERD), sponsored by Dexa Medica. Started Aug 2018; status: terminated.
02
Drugs
Redacid
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03367195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03367195.